Sign in to fuzzto save your conversations, follow your research and come back anytime.
Emcure Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,556.16 | 1,663.09 | 1,667.64 | 1,771.36 | 1,815.14 | 2,001.98 | 1,962.63 | 2,116.25 | 2,100.54 | 2,269.82 | 2,363.48 | 2,469.7 | 2,580.45 |
| Expenses | 1,260.55 | 1,334.05 | 1,373.93 | 1,460 | 1,478.82 | 1,621.11 | 1,608.02 | 1,713.84 | 1,683.76 | 1,794.34 | 1,870.73 | 1,990.15 | 2,047.95 |
| EBITDA | 295.61 | 329.04 | 293.71 | 311.36 | 336.32 | 380.87 | 354.61 | 402.41 | 416.78 | 475.48 | 492.75 | 479.55 | 532.5 |
| Depreciation | 67.18 | 70.28 | 84.39 | 90.56 | 93.59 | 96.9 | 96.81 | 96.84 | 99.46 | 104.64 | 104.68 | 106.27 | 109.51 |
| EBIT | 228.43 | 258.76 | 209.32 | 220.8 | 242.73 | 283.97 | 257.8 | 305.57 | 317.32 | 370.84 | 388.07 | 373.28 | 422.99 |
| Interest | 52.07 | 58.94 | 60.65 | 65.49 | 58.76 | 46.22 | 31.78 | 39.03 | 26.76 | 32.54 | 37.98 | 46.4 | 31.54 |
| Profit Before Tax | 176.36 | 199.82 | 148.67 | 155.31 | 183.97 | 237.75 | 226.02 | 266.54 | 290.56 | 338.3 | 350.09 | 326.88 | 391.45 |
| Net Profit | 140.97 | 145.84 | 119.76 | 121.02 | 152.59 | 201.55 | 156.09 | 197.24 | 214.79 | 251.37 | 231.37 | 243.74 | 292.49 |
| EPS | 7.21 | 7.7 | 6.27 | 6.36 | 7.95 | 10.23 | 8.12 | 9.97 | 10.92 | 12.85 | 12.16 | 12.84 | 15.5 |
| Metric (₹ crore) | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 444.24 | 500.3 | 704.44 | 768.21 | 746.85 | 1,097.24 | 851.71 | 943.55 |
| Investing Cash Flow | -408.77 | -167.93 | -256.47 | -574.49 | -467.81 | -714.51 | -96.05 | -1,174.9 |
| Financing Cash Flow | -735.08 | -300.51 | -188.9 | -151.85 | -145.4 | -164.21 | -813.96 | 343.43 |
| Net Cash Flow | -699.61 | 31.86 | 259.07 | 41.87 | 133.64 | 218.52 | -58.3 | 112.08 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 1,754.59 | 1,900.36 | 1,984.36 | 2,368.01 | 2,114.14 | 2,649.66 | 3,121.76 | 4,641.56 | 4,976.67 |
| Total Liabilities | 3,492.67 | 3,743.72 | 4,019.69 | 4,439.39 | 3,949.33 | 4,022.87 | 4,684.4 | 3,591.17 | 4,635.81 |
| Total Assets | 5,247.26 | 5,644.08 | 6,004.06 | 6,807.4 | 6,063.47 | 6,672.53 | 7,806.16 | 8,232.72 | 9,612.48 |